TREM2 and Alzheimer disease: Using whole exome, whole genome and Sanger sequencing data from 1092 AD patients and 1107 control samples, the group was able to demonstrate the presence of an excess of variants in the second exon of TREM2 in AD relative to controls (p = 0.02), as well as a number of variants found exclusively in either case or control samples.